Mohamad A. Cherry

Mohamad A. Cherry

Hematology | Oncology

100 Madison Avenue
Carol G Simon Cancer Center 2nd Floor Null
Morristown, NJ 07960

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Trends and Demographic Disparities in Primary Immunodeficiency-Related Mortality in the United States: A Nationwide Analysis.

Trends and Demographic Disparities in Primary Immunodeficiency-Related Mortality in the United States: A Nationwide Analysis.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: May 03, 2026

OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL.

OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL.

Journal: Blood advances

Published: March 25, 2024

Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML.

Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 28, 2023

Gray zone lymphoma: A case report and comprehensive review of literature.

Gray zone lymphoma: A case report and comprehensive review of literature.

Journal: Leukemia research reports

Published: April 16, 2023

Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities.

Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities.

Journal: Frontiers in oncology

Published: July 25, 2021

Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Journal: Frontiers in immunology

Published: February 08, 2021

Point-of-Care Assays Could Be Useful for Therapeutic Drug Monitoring of IBD Patients in a Proactive Strategy with Adalimumab.

Point-of-Care Assays Could Be Useful for Therapeutic Drug Monitoring of IBD Patients in a Proactive Strategy with Adalimumab.

Journal: Journal of clinical medicine

Published: June 30, 2020

Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm.

Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm.

Journal: Hematology/oncology clinics of North America

Published: April 28, 2020

Combination trial of duvelisib (IPI-145) with rituximab or bendamustine/rituximab in patients with non-Hodgkin lymphoma or chronic lymphocytic leukemia.

Combination trial of duvelisib (IPI-145) with rituximab or bendamustine/rituximab in patients with non-Hodgkin lymphoma or chronic lymphocytic leukemia.

Journal: American journal of hematology

Published: April 04, 2019

Granulocytic sarcoma and mediastinal germ cell tumor: A common cell of origin?

Granulocytic sarcoma and mediastinal germ cell tumor: A common cell of origin?

Journal: Hematology/oncology and stem cell therapy

Published: April 13, 2018

Sustained response to lenalidomide for early relapsed marginal zone lymphoma.

Sustained response to lenalidomide for early relapsed marginal zone lymphoma.

Journal: Blood cells, molecules & diseases

Published: February 12, 2018

Harnessing the PD-1 Pathway in Myelodysplastic Syndrome.

Harnessing the PD-1 Pathway in Myelodysplastic Syndrome.

Journal: American journal of therapeutics

Published: February 03, 2018

Showing 1-12 of 36

Last Updated: 09/26/2026